Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Berberine modulates cisplatin sensitivity of human gastric cancer cells by upregulation of miR-203
You He-yi, Xuemeng Xie, Weijian Zhang, et al.
In Vitro Cellular & Developmental Biology - Animal (2016) Vol. 52, Iss. 8, pp. 857-863
Closed Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs
James A. McCubrey, Kvin Lertpiriyapong, Linda S. Steelman, et al.
Aging (2017) Vol. 9, Iss. 6, pp. 1477-1536
Open Access | Times Cited: 222
Berberine as a Potential Anticancer Agent: A Comprehensive Review
Abdur Rauf, Tareq Abu‐Izneid, Anees Ahmed Khalil, et al.
Molecules (2021) Vol. 26, Iss. 23, pp. 7368-7368
Open Access | Times Cited: 191
Anticancer Effects and Mechanisms of Berberine from Medicinal Herbs: An Update Review
Ruo-Gu Xiong, Siyu Huang, Si-Xia Wu, et al.
Molecules (2022) Vol. 27, Iss. 14, pp. 4523-4523
Open Access | Times Cited: 84
Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic Reprogramming and Oxidative Stress of Cancer Cells in Various Cancers
Yi‐Ting Chen, Jieling Ning, Wenjie Cao, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 88
Nano-based delivery systems for berberine: A modern anti-cancer herbal medicine
Hossein Majidzadeh, Mostafa Araj‐Khodaei, Maryam Ghaffari, et al.
Colloids and Surfaces B Biointerfaces (2020) Vol. 194, pp. 111188-111188
Closed Access | Times Cited: 79
BCL-w: apoptotic and non-apoptotic role in health and disease
Mariusz L. Hartman, Małgorzata Czyż
Cell Death and Disease (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 74
Berberine for gastric cancer prevention and treatment: Multi-step actions on the Correa’s cascade underlie its therapeutic effects
Qingsong Liu, Jianyuan Tang, Shuanglan Chen, et al.
Pharmacological Research (2022) Vol. 184, pp. 106440-106440
Closed Access | Times Cited: 54
Berberine: An Important Emphasis on Its Anticancer Effects through Modulation of Various Cell Signaling Pathways
Saleh A. Almatroodi, Mohammed A. Alsahli, Arshad Husain Rahmani
Molecules (2022) Vol. 27, Iss. 18, pp. 5889-5889
Open Access | Times Cited: 53
Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers
Luying He, Zhangfeng Zhong, Man Chen, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 42
Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity
Zedong Xiang, Huida Guan, Xiang Zhao, et al.
Phytomedicine (2024) Vol. 126, pp. 155444-155444
Closed Access | Times Cited: 8
Regulatory effects of berberine on microRNome in Cancer and other conditions
Seyed Hasan Ayati, Badrieh Fazeli, Amir Abbas Momtazi‐Borojeni, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 116, pp. 147-158
Closed Access | Times Cited: 84
Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution
Ana C. Henriques, Diana Ribeiro, Joel Pedrosa, et al.
Cancer Letters (2018) Vol. 440-441, pp. 64-81
Closed Access | Times Cited: 81
Anticancer effect of berberine based on experimental animal models of various cancers: a systematic review and meta-analysis
Jianhao Xu, Yuming Long, Liwei Ni, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 68
Silencing of lncRNA CCDC26 Restrains the Growth and Migration of Glioma Cells In Vitro and In Vivo via Targeting miR-203
Shilei Wang, Yuzuo Hui, Xiaoming Li, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2017) Vol. 26, Iss. 8, pp. 1143-1154
Open Access | Times Cited: 64
Recent Advances in Berberine Inspired Anticancer Approaches: From Drug Combination to Novel Formulation Technology and Derivatization
Solomon Habtemariam
Molecules (2020) Vol. 25, Iss. 6, pp. 1426-1426
Open Access | Times Cited: 53
Berberine—A potent chemosensitizer and chemoprotector to conventional cancer therapies
Nalini Devarajan, Selvaraj Jayaraman, Jaideep Mahendra, et al.
Phytotherapy Research (2021) Vol. 35, Iss. 6, pp. 3059-3077
Closed Access | Times Cited: 47
Novel epigenetic therapeutic strategies and targets in cancer
Quratulain Babar, Ayesha Saeed, Tanveer A. Tabish, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2022) Vol. 1868, Iss. 12, pp. 166552-166552
Open Access | Times Cited: 29
Cancer Metabolism as a Therapeutic Target and Review of Interventions
Matthew Halma, Jack A. Tuszyński, Paul E. Marik
Nutrients (2023) Vol. 15, Iss. 19, pp. 4245-4245
Open Access | Times Cited: 19
Pharmacotherapeutic values of berberine: A Chinese herbal medicine for the human cancer management
Nalini Devarajan, Jhansi Nathan, Mathangi Ramalingam, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 37, Iss. 3
Closed Access | Times Cited: 17
The therapeutic effects of berberine for gastrointestinal cancers
Amirhossein Davoodvandi, Sahand Sadeghi, Seyed Mohammad Amin Alavi, et al.
Asia-Pacific Journal of Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 152-167
Open Access | Times Cited: 17
Regulation of Cell Signaling Pathways by Berberine in Different Cancers: Searching for Missing Pieces of an Incomplete Jig-Saw Puzzle for an Effective Cancer Therapy
Ammad Ahmad Farooqı, Muhammad Zahid Qureshi, Sumbul Khalid, et al.
Cancers (2019) Vol. 11, Iss. 4, pp. 478-478
Open Access | Times Cited: 54
<p>Berberine induces apoptosis in non-small-cell lung cancer cells by upregulating miR-19a targeting tissue factor</p>
Qianqian Chen, Jiamin Shi, Ding Zhou, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 9005-9015
Open Access | Times Cited: 51
Bioactive Ingredients in Chinese Herbal Medicines That Target Non-coding RNAs: Promising New Choices for Disease Treatment
Dong Yan, Hengwen Chen, Jialiang Gao, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 50
MicroRNAs in gastric cancer: Biomarkers and therapeutic targets
Soudeh Ghafouri‐Fard, Reza Vafaee, Hamed Shoorei, et al.
Gene (2020) Vol. 757, pp. 144937-144937
Closed Access | Times Cited: 46
Cancer Pathways Targeted by Berberine: Role of microRNAs
Mansoor Ali, Deepali Mishra, Rana P. Singh
Current Medicinal Chemistry (2024) Vol. 31, Iss. 32, pp. 5178-5198
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top